Skip to main content
SpringerLink
Log in

Hypoparathyroidism and Hypocalcemia

  • Chapter
Challenging Cases in Endocrinology

Part of the book series: Contemporary Endocrinology ((COE))

  • 180 Accesses

Abstract

This 33-yr-old man presented with recurrent kidney stones and hypercalcemia, and was diagnosed as having primary hyperparathyroidism (serum Ca 10–12 mg/dL, serum PTH 95 pg/mL). Further work-up demonstrated a growth hormone and prolactin secreting pituitary tumor, a spinal cord ependymoma, and an insulinoma; therefore, a diagnosis of MEN 1 Syndrome was made. During the parathyroidectomy in May 1999, parathyroid hyperplasia was discovered and total parathyroidectomy with autotransplantation to the left forearm was performed.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 189.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 249.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kraimps JL, Duh QY, Demeure M, et al. Hyperparathyroidism in multiple endocrine neoplasia syndrome. Surgery 1992; 112: 1080–1088.

    PubMed  CAS  Google Scholar 

  2. O’Riordan DS, O’Brien T, Grant CS, et al. Surgical management of primary hyperparathyroidism in multiple endocrine neoplasia types 1 and 2. Surgery 1993; 114: 1031–1039.

    Google Scholar 

  3. Hellman P, Skogseid B, Oberg K, et al. Primary and reoperative parathyroid operations in hyperparathyroidism of multiple endocrine neoplasia type 1. Surgery 1998; 124: 993–999.

    Article  PubMed  CAS  Google Scholar 

  4. Proye C, Carnaille B, Quievreux JL, et al. Late outcome of 304 consecutive patients with multiple gland enlargement in primary hyperparathyroidism treated by conservative surgery. World J Surg 1998; 22: 526–530.

    Article  PubMed  CAS  Google Scholar 

  5. Olson JA, DeBenedetti MK, Bauman DS et al. Parathyroid autotransplantation during thyroidectomy. Results of long-term follow-up. Ann Surg 1996; 223: 472–480.

    Article  PubMed  Google Scholar 

  6. Broadus AE. Mineral balance and homeostasis. In: Favus MJ, ed. Primer on the metabolic bone disease, 4th ed. Lippincott, Philadelphia, PA, 1999, pp. 74–80.

    Google Scholar 

  7. Guise TA, Mundy GR. Evaluation of hypocalcemia in children and adults. J Clin Endocrinol Metab 1995; 80: 1473–1478.

    Article  PubMed  CAS  Google Scholar 

  8. Heaney RP. Absorption of calcium as the carbonate and citrate salts, with some observation on method. Osteoporosis Int 1999; 9: 19–23.

    Article  CAS  Google Scholar 

  9. Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr 1999; 69: 842–856.

    PubMed  CAS  Google Scholar 

  10. Veldhuis JD, Norton JA, Wells SA Jr, et al. Theraputic controversy. Surgical versus medical management of multiple endocrine neoplasia (MEN) type 1. J Clin Endocrinol Metab 1997; 82: 357–364.

    Article  PubMed  CAS  Google Scholar 

  11. Wells SA Jr, Ellis GJ, Gunnells JC, et al. Parathyroid autotransplantation in primary parathyroid hyperplasia. N Engl J Med 1976; 195: 57–62.

    Article  Google Scholar 

  12. Wells SA Jr, Gunnels JC, Gutman RA, et al. The successful transplantation of frozen parathyroid tissue in man. Surgery 1977; 81: 86–90.

    PubMed  Google Scholar 

  13. Saxe AW, Brennan MF. Reoperative parathyroid surgery for primary hyperparathyroidism caused by multiple-gland disease: total parathyroidectomy and autotransplantation with cryopreserved tissue. Surgery 1982; 91: 616–621.

    PubMed  CAS  Google Scholar 

  14. Herrera M, Grant C, vanHeerden JA, et al. Parathyroid autotransplantation. Arch Surg 1992; 127: 825–830.

    Article  PubMed  CAS  Google Scholar 

  15. Caccitolo J, Farley DR, vanHeerden JA, et al. The current role of parathyroid cryopreservation and autotransplantation in parathyroid surgery: an institutional experience. Surgery 1997; 122: 1062–1067.

    Article  PubMed  CAS  Google Scholar 

  16. Mallette LE, Blevins T, Jordan P, et al. Autogenous parathyroid grafts for generalized primary parathyroid hyperplasia: contrasting outcome in sporadic hyperplasia versus multiple endocrine neoplasia type I. Surgery 1987; 101: 738–745.

    PubMed  CAS  Google Scholar 

  17. Carling T, Rastad J, Ridefelt P, et al. Hyperparathyroidism of multiple endocrine neoplasia type 1: candidate gene and parathyroid calcium sensing protein expression. Surgery 1995; 118: 924–931.

    Article  PubMed  CAS  Google Scholar 

  18. McHenry CR, Stenger DB, Calandro NK. The effect of cryopreservation on parathyroid cell viability and function. Am J Surg 1997; 174: 481–484.

    Article  PubMed  CAS  Google Scholar 

  19. Strewler GJ, Rosenblatt M. Mineral metabolism. In: Felig P, Baxter JD, Frohman LA, eds. Endocrinology and Metabolism, 3rd ed, McGraw-Hill, New York, 1995, pp. 1407–1516.

    Google Scholar 

  20. Kovacs CS, Kronenberg HM. Maternal-fetal calcium and bone metabolism during pregnancy, puerperium and lactation. Endocr Rev 1997; 18: 832–872.

    Article  PubMed  CAS  Google Scholar 

  21. Cornish J, Callon KE, Nicholson GC, Reid IR. Parathyroid hormone-related protein-(107–139) inhibits bone resorption in vivo. Endocrinology 1997; 138: 1299–1304.

    Article  PubMed  CAS  Google Scholar 

  22. Callies F, Arlt W, Scholz HJ, et al. Management of hypoparathyroidism during pregnancy-report of twelve cases. Eur J Endocrinol 1998; 139: 284–289.

    Article  PubMed  CAS  Google Scholar 

  23. Salle BL, Berthezene F, Glorieux FH, et al. Hypoparathyroidism during pregnancy: treatment with calcitriol. J Clin Endocrinol Metab 1981; 52: 810–813.

    Article  PubMed  CAS  Google Scholar 

  24. Caplan RH, Beguin EA. Hypercalcemia in a calcitriol-treated hypoparathyroid woman during lactation. Obstet Gynecol 1990; 76: 485–489.

    PubMed  CAS  Google Scholar 

  25. Dobnig H, Kainer F, Stepan V, et al. Elevated parathyroid hormone-related peptide levels after human gestation: relationship to changes in bone and mineral metabolism. J Clin Endocrinol Metab 1995; 80: 3699–3707.

    Article  PubMed  CAS  Google Scholar 

  26. Mather KJ, Chik CL, Corenblum B. Maintenance of serum calcium by parathyroid hormone-related peptide during lactation in a hypoparathyroid patient. J Clin Endocrinol Metab 1999; 84: 424–427.

    Article  PubMed  CAS  Google Scholar 

  27. Cundy T, Haining SA, Guilland-Cumming DF, et al. Remission of hypoparathyroidism during lactation: evidence for a physiological role for prolactin in the regulation of vitamin D metabolism. Clin Endocrinol 1987; 26: 667–674.

    Article  CAS  Google Scholar 

  28. Hoper K, Pavel M, Dorr G, et al. Calcitriol-Gabe in der Scwangerschaft bei partieller Di-Geroge-Anomalie. Deutsche Medizinische Wochenschrift 1994; 119: 176–178.

    Article  Google Scholar 

  29. Eastell R, Edmonds CJ, deDhayal RCS, McFadyen IR. Prolonged hypoparathyroidism presenting as second trimester abortion. Br Med J 1985; 291: 955–956.

    Article  CAS  Google Scholar 

  30. Loughead JL, Mughal Z, Mimouni F, et al. Spectrum and natural history of congenital hyperparathyroidism secondary to maternal hypocalcemia. Am J Perinatol 1990; 7: 350–355.

    Article  PubMed  CAS  Google Scholar 

  31. Friedman WF, Mills LF. The relationship between vitamin D and craniofacial and dental anomalies of the supravalvular aortic stenosis syndrome. Pediatrics 1969; 43: 12–18.

    PubMed  CAS  Google Scholar 

  32. Pylypchuk G, Oreopoulos, Wilson DR, et al. Calcium metabolism in adult outpatients with epilepsy receiving long-term anticonvulsant therapy. Can Med Assoc J 1978; 118: 635–638.

    PubMed  CAS  Google Scholar 

  33. Weinstein RS, Bryce GF, Sappington LJ, et al. Decreased serum ionized calcium and normal vitamin D metabolite levels with anticonvulsant drug treatment. J Clin Endocrinol Metab 1984; 58: 1003–1009.

    Article  PubMed  CAS  Google Scholar 

  34. Hahn TJ, Hendin BA, Scharp CR, Haddad JGJ. Effect of chronic anticonvulsant therapy on serum 25hydroxycalciferol levels in adults. N Engl J Med 1972; 287: 900–904.

    Article  PubMed  CAS  Google Scholar 

  35. Matheson RT, Herbst JJ, Jubiz W, et al. Absorption and biotransformation of cholecalciferol in drug-induced osteomalacia. J Clin Pharmacol 1976; 16: 426–432.

    Article  PubMed  CAS  Google Scholar 

  36. Corradino RA. Diphenylhydantoin: direct inhibition of the vitamin D3-mediated calcium absorptive mechanism in organ-cultured duodenum. Biochem Pharmacol 1976; 25: 863–864.

    Article  PubMed  CAS  Google Scholar 

  37. Hahn Ti, Scharp CR, Richardson CA, et al. Interaction of diphenylhydantoin (phenytoin) and phenobarbital with hormonal mediation of fetal rat bone resorption in vitro. J Clin Invest 1978; 62: 406–414.

    Article  PubMed  CAS  Google Scholar 

  38. Scire G, Dallapiccola B, Iannetti P, et al. Hypoparathyroidism as the major manifestation in two patients with 22811 deletion. Am J Med Genet 1994; 52: 478–482.

    Article  PubMed  CAS  Google Scholar 

  39. Raskin P, McClain CJ, MedsgerTA. Hypocalcemia associated with metastatic bone disease. A retrospective study. Arch Intern Med 1973; 132: 539–543.

    Article  PubMed  CAS  Google Scholar 

  40. Riancho JA, Arjona R, Valle R, Sanz J, Gonzalez-Macias J. The clinical spectrum of hypocalcemia associated with bone metastases. J Intern Med 1989; 226: 449–452.

    Article  PubMed  CAS  Google Scholar 

  41. Kukreja SC, Shanmugam A, Lad TE. Hypocalcemia in patients with prostate Cancer. Calcif Tissue Int 1988; 43: 340–345.

    Article  PubMed  CAS  Google Scholar 

  42. Ladenson JH, Lewis JW, Boyd JC. Failure of total calcium corrected for protein, albumin, and pH to correctly assess free calcium status. J Clin Endocrinol Metab 1978; 46: 986–993.

    Article  PubMed  CAS  Google Scholar 

  43. Shemerdiak WP, Kukreja SC, Lad TE, York PA, Henderson WJ. Evaluation of routine ionized calcium determination in cancer patients. Clin Chem 1981; 27: 1621–1622.

    PubMed  CAS  Google Scholar 

  44. Thode J, Juul-Jorgensen B, Bhatia HM, Kjaerulf-Nielsen M, Bartels PD, Fogh-Andersen N, SiggaardAndersen O. Comparison of serum total calcium, albumin-corrected total calcium, and ionized calcium in 1213 patients with suspected calcium disorders. Scand J Clin Lab Invest 1989; 49: 217–223.

    Article  PubMed  CAS  Google Scholar 

  45. Chase LR, Slatopolsky E. Secretion and metabolic efficacy of parathyroid hormone in patients with severe hypomagnesemia. J Clin Endocrinol Metab 1974; 38: 363–371.

    Article  PubMed  CAS  Google Scholar 

  46. Hanley DA, Sherwood LM. Secondary hyperparathyroidism in chronic renal failure: pathophysiology and treatment. Med Clin North Am 1978; 62: 1319–1339.

    PubMed  CAS  Google Scholar 

  47. Suzuki T, Ikeda U, Fujikawa H, Saito K, Shimada K. Hypocalcemic heart failure: a reversible form of heart muscle disease. Clin Cardiol 1998; 21: 227–228.

    Article  PubMed  CAS  Google Scholar 

  48. Zaloga GP. Hypocalcemia in critically ill patients. Crit Care Med 1992; 20: 251–262.

    Article  PubMed  CAS  Google Scholar 

  49. Jankowski S, Vincent JL. Calcium administration for cardiovascular support in critically ill patients: when is it indicated? J Intensive Care Med 1995; 10: 91–100.

    PubMed  CAS  Google Scholar 

  50. Kukla LJ, Abramson EC, McGuire WP, Shevrin DH, Lad T, Kukreja SC. Cis-platinum treatment for malignancy-associated humoral hypercalcemia in an athymic mouse model. Calcif Tissue Int 1984; 36: 559–562.

    Article  PubMed  CAS  Google Scholar 

  51. Comlekci A, Biberoglu S, Hekimsoy Z, Okan I, Piskin O, Sekeroglu B, Alakavuklar M. Symptomatic hypocalcemia in a patient with latent hypoparathyroidism and breast carcinoma with bone metastasis following administration of pamidronate. Intern Med 1998; 37: 396–397.

    Article  PubMed  CAS  Google Scholar 

  52. Cadman EC, Lunberg WB, Bertino JR. hyperphosphatemia and hypocalcemia accompanying rapid cell lysis in a patient with Burkitt’s lymphoma and Burkitt cell leukemia. Am J Med 1977; 62: 283–290.

    Article  PubMed  CAS  Google Scholar 

  53. Sackner MA, Apivack AP, Balian LJ. Hypocalcemia in the presence of osteoblastic metastases. N Engl J Med 1960; 262: 173–176.

    Article  PubMed  CAS  Google Scholar 

  54. Randall RE Jr, Lirenman DS. Hypocalcemia and hypophosphatemia accompanying osteoblastic metastases. J Clin Endocrinol Metab 24: 1331–1334.

    Google Scholar 

  55. Hall TC, Griffiths CT, Petranek JR. Hypocalcemia-an unusual metabolic complication of breast cancer. N Engl J Med 1966; 275: 1474–1477.

    Article  PubMed  CAS  Google Scholar 

  56. Tommaso CL, Tucci JR. Metabolic studies in a case of hypocalcemia and osteoblastic metastases. Arch Intern Med 1979; 139: 238–241.

    Article  PubMed  CAS  Google Scholar 

  57. Smallridge RC, Wray HL, Schaaf M. Hypocalcemia with osteoblastic metastases in patient with prostate carcinoma. A cause of secondary hyperparathyroidism. Am J Med 1981; 71: 184–188.

    Article  PubMed  CAS  Google Scholar 

  58. Schenkein DP, O’Neill WC, Shapiro J, Miller KB. Accelerated bone formation causing profound hypocalcemia in acute leukemia. Ann Intern Med 1986; 105: 375–378.

    PubMed  CAS  Google Scholar 

  59. Sy WM, Patel D, Faunce H. Significance of absent or faint kidney sign on bone scan. J Nucl Med 1975; 16: 454–456.

    PubMed  CAS  Google Scholar 

  60. Jacobs SC, Pikna D, Lawson RK. Prostatic osteoblastic factor. Invest Urol 1979; 17: 195–198.

    PubMed  CAS  Google Scholar 

  61. Simpson E, Harrod J, Eilon G, Jacobs JW, Mundy GR. Identification of a messenger ribonucleic acid fraction in human prostatic cancer cells coding for a novel osteoblast-stimulating factor. Endocrinology 1985; 117: 1615–1620.

    Article  PubMed  CAS  Google Scholar 

  62. Rabbani SA, Xing RH. Role of urokinase (uPA) and its receptor (uPAR) in invasion and metastasis of hormone-dependent malignancies. Int J Oncol 1998; 12: 911–920.

    PubMed  CAS  Google Scholar 

  63. Achbarou A, Kaiser S, Tremblay G, Ste-Marie LG, Brodt P, Goltzman D, Rabbani SA. Urokinase overproduction results in increased skeletal metastasis by prostate cancer cells in vivo. Cancer Res 1994; 54: 2372–2377.

    PubMed  CAS  Google Scholar 

  64. Festuccia C, Teti A, Bianco P, Guerra F, Vicentini C, Tennina R, Villanova I, Sciortino G, Bologna M. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma. Oncol Res 1997; 9: 419–431.

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. Elena I. Barengolts MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Subhash C. Kukreja MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Center for Endocrinology, Metabolism, and Molecular Medicine, Northwestern University Medical School, Chicago, IL, USA

    Mark E. Molitch MD

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer Science+Business Media New York

About this chapter

Cite this chapter

Barengolts, E.I., Kukreja, S.C. (2002). Hypoparathyroidism and Hypocalcemia. In: Molitch, M.E. (eds) Challenging Cases in Endocrinology. Contemporary Endocrinology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-277-7_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-59259-277-7_11

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-61737-249-0

  • Online ISBN: 978-1-59259-277-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation